1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Multiple Myeloma, Neoplasms: new trials by email Literature Review of Multiple Myeloma, Neoplasms trials Research Report on Multiple Myeloma, Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers cetuximab, vemurafenib - Multiple Myeloma, Neoplasms | Phase 2 | Completed | Hoffmann-La Roche | 208 | 2012-04-12 | 2017-11-20 |
Multiple Myeloma (1) · Neoplasms (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1) · Vascular Diseases (1)
Cetuximab (1) · Vemurafenib (1)
China (1) · France (1) · Germany (1) · Spain (1) · United Kingdom (1) · United States (1)